{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:32:33Z","timestamp":1778049153987,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.vaccine.2007.05.042","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T13:04:30Z","timestamp":1181567070000},"page":"6544-6556","source":"Crossref","is-referenced-by-count":73,"title":["Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response"],"prefix":"10.1016","volume":"25","author":[{"given":"Sudipta","family":"Bhowmick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(00)90055-5","article-title":"Visceral leishmaniasis control: a public health perspective","volume":"94","author":"Boelaert","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"16","key":"10.1016\/j.vaccine.2007.05.042_bib3","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1517\/14656566.6.16.2821","article-title":"Treatment of visceral leishmaniasis","volume":"6","author":"Sundar","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"10.1016\/j.vaccine.2007.05.042_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/14712598.4.9.1505","article-title":"Recent advances in vaccines for leishmaniasis","volume":"4","author":"Requena","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"9241","key":"10.1016\/j.vaccine.2007.05.042_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.05.042_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"Velez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report","volume":"99","author":"Convit","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.05.042_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.05.042_bib11","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.042_bib12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9496","key":"10.1016\/j.vaccine.2007.05.042_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.05.042_bib15","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.112.18.2993","article-title":"Leishmania species: models of intracellular parasitism","volume":"112","author":"Alexander","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1016\/j.vaccine.2007.05.042_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?","volume":"201","author":"Mahon-Pratt","year":"2004","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.042_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.185.5.867","article-title":"Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model","volume":"185","author":"Murray","year":"1997","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib19","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib20","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.042_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/IAI.62.3.1058-1063.1994","article-title":"Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis","volume":"62","author":"Miralles","year":"1994","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.042_bib22","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.4049\/jimmunol.142.12.4441","article-title":"Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen\/liposomes. Optimization and assessment of the requirement for intravenous immunization","volume":"142","author":"Kahl","year":"1989","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.05.042_bib23","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2005.10.025","article-title":"Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis","volume":"24","author":"Sharma","year":"2006","journal-title":"Vaccine"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2007.05.042_bib24","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice","volume":"24","author":"Jaafari","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.042_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","article-title":"Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Felnerova","year":"2004","journal-title":"Curr Opin Biotechnol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.042_bib26","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","article-title":"Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes","volume":"65","author":"Afrin","year":"1997","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2307\/3284319","article-title":"Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes","volume":"83","author":"Ali","year":"1997","journal-title":"J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.042_bib28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1645\/0022-3395(2000)086[0730:IOPPAL]2.0.CO;2","article-title":"Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes","volume":"86","author":"Afrin","year":"2000","journal-title":"J Parasitol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.042_bib29","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/bj1290123","article-title":"Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats","volume":"129","author":"Gregoriadis","year":"1972","journal-title":"Biochem J"},{"issue":"5259","key":"10.1016\/j.vaccine.2007.05.042_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(81)90179-2","article-title":"Silver staining of proteins in polyacrylamide gels","volume":"118","author":"Wray","year":"1981","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.042_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An 8-day method for screening compounds against Leishmania donovani in the golden hamster","volume":"5","author":"Stauber","year":"1958","journal-title":"J Protozool"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.05.042_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A mixed Th1\/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB\/c mice","volume":"22","author":"Mazumdar","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2007.05.042_bib36","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2007.05.042_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3050307","article-title":"Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.vaccine.2007.05.042_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.57.3.754-763.1989","article-title":"Inhibition of Leishmania donovani promastigote internalization into murine macrophages by chemically defined parasite glycoconjugate ligands","volume":"57","author":"Palatnik","year":"1989","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.042_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00160-9","article-title":"Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2","volume":"130","author":"Becker","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"21","key":"10.1016\/j.vaccine.2007.05.042_bib41","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1016\/S0021-9258(18)61124-X","article-title":"Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan","volume":"262","author":"Orlandi","year":"1987","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.vaccine.2007.05.042_bib42","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.05.042_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","article-title":"Mechanism and regulation of immunoglobulin isotype switching","volume":"54","author":"Coffman","year":"1993","journal-title":"Adv Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.05.042_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.042_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-409X(99)00064-2","article-title":"Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells","volume":"41","author":"Rao","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.042_bib46","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/eji.200526193","article-title":"CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo","volume":"36","author":"Serre","year":"2006","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib47","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.161.8.4000","article-title":"Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen","volume":"161","author":"Brewer","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.05.042_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","article-title":"The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development","volume":"201","author":"Scott","year":"2004","journal-title":"Immunol Rev"},{"issue":"5144","key":"10.1016\/j.vaccine.2007.05.042_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib50","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis","volume":"160","author":"Sjolander","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0092-8674(93)90542-X","article-title":"The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells","volume":"75","author":"Kamogawa","year":"1993","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/eji.1830220511","article-title":"Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction","volume":"22","author":"Platzer","year":"1992","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.05.042_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.181.2.537","article-title":"Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production","volume":"181","author":"D\u2019Andrea","year":"1995","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.05.042_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2736(91)90160-A","article-title":"Interaction of positively-charged liposomes with blood: implications for their application in vivo","volume":"1070","author":"Senior","year":"1991","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.vaccine.2007.05.042_bib55","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib56","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2007.05.042_bib57","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J Immunol"},{"issue":"8530","key":"10.1016\/j.vaccine.2007.05.042_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Convit","year":"1987","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.vaccine.2007.05.042_bib59","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/S0264-410X(00)00109-2","article-title":"Therapy of murine cutaneous leishmaniasis by DNA vaccination","volume":"18","author":"Handman","year":"2000","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.042_bib60","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2307\/3284581","article-title":"Isotype profiles of Leishmania donovani-infected BALB\/c mice: preferential stimulation of IgG2a\/b by liposome-associated promastigote antigens","volume":"84","author":"Afrin","year":"1998","journal-title":"J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.05.042_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1550-7408.2002.tb00369.x","article-title":"Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasite","volume":"49","author":"Dey","year":"2002","journal-title":"J Eukaryot Microbiol"},{"issue":"32","key":"10.1016\/j.vaccine.2007.05.042_bib62","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1016\/S0264-410X(03)00527-9","article-title":"Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine","volume":"21","author":"Santos","year":"2003","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2007.05.042_bib63","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1016\/j.vaccine.2006.03.005","article-title":"Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani","volume":"24","author":"Gamboa-Leon","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.05.042_bib64","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4049\/jimmunol.161.8.4153","article-title":"Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani","volume":"161","author":"Murphy","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.05.042_bib65","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.2042-7158.1988.tb05271.x","article-title":"The therapeutic effect of sodium stibogluconate in BALB\/c mice infected with Leishmania donovani is organ-dependent","volume":"40","author":"Carter","year":"1988","journal-title":"J Pharm Pharmacol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07006160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:27:39Z","timestamp":1683887259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07006160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":65,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0264410X07006160"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.05.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}